Introduction

Head and neck cancer and hypoxia
Squamous cell carcinoma of the head and neck (HNSCC) describes aggressive, malignant disease affecting sites such as the oral cavity, pharynx, oropharynx, tongue, nasopharynx and oesophagus. Cancers of the head and neck account for approximately 3% of all human malignancies and approximately 500 000 HNSCC are diagnosed world wide each year, with the majority being locally advanced at presentation (Bourhis et al 2006) . Surgery, radiotherapy and chemotherapy may be used alone or in combination to control the disease, with radiotherapy being the most common form of treatment. Currently, radiotherapy local control rates are approximately 80% for early stage disease, but this becomes significantly lower (often below 50%) for locally advanced tumours. Efforts to improve these statistics through dose and fractionation modifications have been made in recent decades using different radiation dose schedules but the prognosis has not improved significantly (Koukourakis et al 2006 , Dinshaw et al 2006 , Stadler et al 1998 .
Hypoxia, defined as a lack of an adequate supply of oxygen in tissue, occurs commonly in HNSCC and is a significant cause of treatment failure because hypoxic cells are up to 3 times more resistant to radiotherapy (Palcic et al 1984 , Gray et al 1953 . From a radiobiological perspective, hypoxia of a cell is said to exist if partial oxygen pressure (pO 2 ) is 10 mm Hg or less. However, reports from clinical trials often express hypoxia as the percentage of cells in the tumour with pO 2 less than 5 or 2.5 mm Hg. The normal range of pO 2 for healthy epithelial cells may range from 20 to 100 mm Hg with an average of 40-50 mm Hg (Adelstein et al 2005 , Adam et al 1999 .
Hypoxia arises in the tumour mass if the oxygen supply is inefficient, which may be due to effects such as the increased demand for oxygen in the rapidly proliferative cell population and the irregular and chaotic nature of tumour vessel networks. Hypoxic regions may be anywhere in the tumour mass but are most commonly observed at the tumour core, which is likely to be located further from functioning blood vessels than at its periphery (chronic hypoxia). Temporary hypoxia (acute hypoxia) may also be observed if there are temporary shortages in blood flow, for reasons such as the fluctuation in mechanical pressures on the tumour.
Approximately 70% of locally advanced head and neck tumours have been shown to have hypoxic regions (Rischin et al 2006 , Becker et al 1998 and there is direct evidence that the hypoxic sub-volume and mean oxygen level have a direct influence on local control of head and neck tumours (Nordsmark et al 2005 , Dunst et al 2003 , Stadler et al 1998 , Brizel et al 1999 , Gatenby et al 1988 . Further, up to 30% difference in time to recurrence and 10% difference in death rates at 5 years has been found in clinical trials when separating patient groups into low and high oxygenation groups (Adam et al 1999 , Nordsmark et al 2005 .
A large range in individual patient values for fractional hypoxic volumes within the tumours exists. Furthermore, there is a wide distribution of oxygen levels within a single tumour. These wide variations provide the basis for developing tumour models and treatment planning algorithms based not only on the presence of hypoxia, but also on the individual hypoxic tumour volumes and the oxygen distribution within the tumour. There is considerable evidence in the literature supporting the value of modelling (Dutching and Vogelsaenger 1985 , Dionysiou et al 2004 , Dasu et al 2005 , Harting et al 2007 based oxygen distribution in the tumour and clinical trial data which stratify for hypoxic volumes (Dunst et al 2003) .
Tumour modelling has the potential for faster and more individualized radiotherapy treatment planning. Modelling allows patient specific biological data to be considered, and allows for changes in parameter values and ranges to be evaluated for their affects on the entire tumour system. Using Monte Carlo modelling methods, cell based parameter changes can be implemented and their impact analysed by varying macroscopic tumour properties such as: tumour growth rates/doubling times (TD), the percentages of cells differing proliferation potential within the tumour population, the percentage of hypoxic cells and the rate of repopulation and reoxygenation throughout treatment. A cell specific and multi-parameter system such as this would not be feasible using an equation based deterministic method of modelling.
Research aims
The broad aims of this study are to develop a HNSCC tumour growth computer model to assess the major influences on tumour growth rate on an individual basis. The model should provide a tool for not only growing a tumour much faster than in a living model, but also for analysis and changes to be included any point in time. It should be relatively simple to use, run efficiently in time and memory capacity and have the flexibility to allow further cell based and global parameters to be applied to the model for further developments. It should also have the flexibility to allow for the effect of individual radiotherapy fractionation schedules and different degrees of tumour oxygenation as well as reoxygenation and repopulation during RT.
Review of the tumour modelling literature
Many groups have undertaken the task of simulating the growth and subsequent treatment of human tumours using mathematical and computer systems. They have done so through various methods which have used either analytical deterministic or stochastic Monte Carlo type approaches. For the more recent models include parameters of constituent tumour cell groups or of individual cells, both methods have been used for an automaton approach to spatially organize and visualize the tumour, or to concentrate purely on the temporal behaviour of the system.
Based on previous work (Gray et al 1953) which showed that cells undergoing radiotherapy are more resistant in the absence of oxygen, Thomlinson and Gray (Thomlinson and Gray 1955) first used the theories of simple geometry and diffusion (Hill 1928) to mathematically predict the presence and location of chronic hypoxia of tumour cell cords. Their model was justified by experimental results which revealed no presence of central necrosis in tumour cell cords in squamous cell carcinoma of the bronchus, which were less than 160 µm in diameter. Work by Tannock followed in the late 1960s and early 1970s which went on to describe the radiosensitivity of tumours based on the distribution of tissue oxygenation (Tannock 1968 , Tannock and Steel 1970 , Tannock 1972 .
Two of the earliest groups to describe the tumour system using stochastic methods and individual cell or cell sub-group modelling were led by Donaghey (1980) and Dutching Vogelsaenger 1981, 1985) during the late 1970s and early 1980s. This work led to the progression into the first stochastic tumour population modelling algorithms (Donaghey 1980 , Smolle and Stettner et al 1993 , Qi et al 1993 and further into modelling the effects of chronic hypoxia in tumours and how the potential doubling time and hypoxic cell life span impacted on the extent of hypoxic in solid tumour segments (Maseide et al 1999) . In more recent times, tumour modelling has become more specific in terms of tumour site, cell characteristics and also to include modelling of treatment parameters to a larger extent (Kocher et al 2000 , Dionysiou et al 2004 , Borkenstein et al 2004 , Harting et al 2007 .
The current model extends upon the work within Department of Medical Physics, developed by Marcu et al (2002) at the Royal Adelaide Hospital and IMVS Research Facility. This work analysed the mechanisms and influences of tumour growth kinetics and was extended to consider the temporal aspects of chemotherapy in combination with radiotherapy and their effects on tumour kinetics and treatment outcome. The work in this text contributes to the tumour modelling literature by providing an individual tumour cell propagation model which includes: an epithelial cell proliferative hierarchy, a plausible log-normal distribution of oxygen amongst the individual tumour cells, oxygen and cell type dependent cell cycle times, cell quiescence and radiosensitivity (for future radiotherapy studies). The model algorithm has been written in FORTRAN 95 which has proven to be efficient for the type of coding required in the model, and has been designed to be efficient and flexible for data handling and storage. It may also be readily developed and extended to further investigations into radiotherapy treatment effects on tumour cell kill for well oxygenated or for hypoxic tumours of varying degrees of oxygenation.
Methods
Modelling tumour cell division
2.1.1. Carcinogenesis and cell hierarchy. There are many theories of how genetically mutated cells progress to develop into a malignant tumour. In this work it has been assumed that HNSCC is initiated by a single mutated stem cell. This cell type is typically found in the basal (lower) layer of epithelial tissue (Leary et al 1984 , Morris et al 2004 . The cell hierarchy structure used in the model was developed through the information provided by previous stem cell biology and modelling work (Aarnaes et al 1990 , Wright and Alison 1984 , Marcu et al 2002 .
Stem cells are self renewing cells, and are often also described as being clonogenic, meaning that they divide indefinitely, and they are responsible for maintaining the integrity of the epithelial tissue by boosting the cell population. Stem cells may be in a proliferative (dividing) or quiescent state. In the lower and intermediate layers of the epithelium, cells with limited proliferative capacity exist, called transit cells. These cells may undergo a finite number of divisions, producing more transit cells or differentiating cells (post-mitotic cells). In the higher layers, cells more specialized and eventually become fully differentiated. Fully differentiated cells are eventually lost through natural cell death processes and replaced through cell division from the layers below. Epithelial tissue of the structures of the head and neck is primarily non-keratinizing (does not form the protein keratin, unlike skin), but like skin it is also stratified, as shown in figure 1.
Cell type definitions programmed cell division structure.
Although the layered structure of normal epithelial tissue may be distorted in tumouros tissue, it has been assumed in the model that the percentages of different cell types are approximately maintained. This assumption is made on the premise that the HNSCC tumour system is one in which the balance between cell production and cell loss no longer exists, although it retains cells of a wide range of proliferative capacities (which may vary depending on tumour differentiation status).
In the model, a dividing stem cell always produces at least one daughter stem cell (a property of self renewing stem cells), and the second daughter cell is either another stem cell, a first generation 'transit' cell ('T1') or a differentiating cell ('D1', a differentiating cell that would in healthy tissue be located in the basal layer). Stem cells may be in a quiescent or cycling state. The ratio of the probabilities for the cell type of the second daughter cell is called the 'S:T1:D1' ratio.
The modelled transit cells divide into two daughter transit cells, until a predefined generation number (between 1 and 4) has been reached (generation number is described as 'T1' for first generation, 'T2' for second generation etc), at which time the last generation transit cell divides in to two differentiating cells ('D1' or 'D2').
The modelled differentiating cells go through three phases before cell death, the 'D1', 'D2' and 'D3' phases. The 'D1', 'D2' phase cells are produced from stem or transit cell divisions. Both the 'D1' and 'D2' cells progress into the 'D3' phase. 'D3' cells are those cells which have become fully differentiated and exist for a finite period before being lost to natural cell death processes (Wright and Alison 1984 , Aarnaes et al 1990 . See figure 2 for a diagram cell types and division products applied in the model.
The primary difference between the healthy tissue and the modelled tumour tissue is the increased probability of stem cell division where two daughter stem cells are produced. This probability is called the stem cell symmetrical division probability and will be referred to as S% (also as 'S' in the S:T1:D1 ratio).
Daughter cell products upon division of the various cell types have been determined in the model based on literature data of the cell type percentages in the total cell population likely to be present in normal epithelial tissue and therefore also in their malignant counterparts (Aarnaes et al 1990 , Wright and Alison 1984 , Steel 2002 , Appleton et al 2002 , Marcu et al 2002 . Aarnaes et al took great detail in mathematically and experimentally exploring the percentages of proliferating and quiescent cells in the basal layer of the epithelium, as well as the different cell cycle and phase durations in cells at different times of the day. The latter parameter does not form part of the current study, although it merits consideration at a later date owing to the impact on the redistribution of cells in the cell cycle during fractionated radiotherapy.
A 12%-50% D1 population amongst the basal layer cells and an approximate 50% proliferating population in the basal layer has been reported (Aarnaes et al 1990) . This group has also estimated the percentage of cells in the G0/G1 phase awaiting migration to be approximately 20% in the basal layer. The total non-cycling population was assumed to be 80%-90% of the total cell population, and that the differentiated group of cells had a high probability of cell death (apoptotic and other natural death processes). These data were noted while adjusting parameters so that the final cell type percentages were in plausible ranges (results presented in section 3.1).
The approach of modelling the cells which do impact significantly on tumour growth rate, more accurately reflects the biology and cell type percentages that have been previously reported (Aarnaes et al 1990 , Wright and Alison 1984 , Marcu et al 2002 . Consequently, effects of parameter values and ranges on the cell populations have been made simpler to analyse in terms of impact upon the cell type percentages.
It should be noted that no DNA or gene mutation information is modelled in this work and only tumour cells (no normal tissue) have been considered. The model does not take into account any spatial information about the cells, i.e., no specific layered structure, as temporal information only is retained for each cell.
Monte Carlo modelling approach 2.2.1. Stochastic modelling technique and programming language.
Monte Carlo modelling techniques were employed so that multiple biological parameters could be considered simultaneously, since many parameters involve the use of probability functions. The program has been written in the FORTRAN 95 programming language and used in the Microsoft Visual Studio 2003 environment. This language was chosen for this project because of the computational speed achievable through the use of basic functions and commands. Early in development, the program was written in the MATLAB programming language and compared in terms of computational speed, using similar basic functions and a programming style. The use of MATLAB showed more than a five fold decrease in computational efficiency.
The simulations that have produced the results in section 3 have used a total cell population of 10 7 cells. This number was chosen to limit the time taken to produce the required results, whilst acquiring a sufficient cell population to model the initiation of tumour hypoxia (10 6 cells). Note that the variations in model in terms of the cell population percentages and tumour growth rates are negligible at this cell number, considering the fluctuations caused by altering the random number seed.
Algorithm design.
The 95 edition of FORTRAN 95 has the advantage of being 'object oriented'. Each cell in the tumour model is declared as an object. Each object may have many attributes assigned to it, each with a different numerical precision if required. For the model in its current state, there are five such attributes stored as integers, in one 4-byte and three 1-byte words. These attributes include: the cell type, generation number, cell cycling time, time at which the cell is due to divide, and the oxygenation level.
The storage of cell data and data handling is structured using a large two-dimensional array of cells. Each element in the array houses one cell or 'object'. The algorithm is designed such that as each cell divides, two new daughter cells emerge and the mother cell ceases to exist. The two new cells are allocated their respective attributes and stored within the array. Each row in the array houses a stack of cells and represents one hour of time (relative to the tumour), i.e., cells which are due to divide within a certain hour are stored in the same stack and remain there until the stack is due to divide. This is an efficient way of organizing the cell data storage and for reading and writing data to computer memory.
The cell division algorithm was designed such that cells divide in chronological order according to their assigned cell cycle time (CCT), followed by multiple parameter assignment to the daughter cell products. All individual cell attributes in the growth model are allocated upon creation of the cell and remain fixed through out its lifetime; however, one daughter cell retains the mother cell oxygenation level, as it effectively replaces the position that the mother cell used to reside. The second daughter cell will have a new oxygen value randomly allocated from a probability distribution.
Stacks of cells are divided in chronological order, at which time daughter cells are created and immediately stored in a new stack, corresponding to their allocated Cell Cycle Time (CCT) and the current tumour time. There are 59 stacks in the array (maximum CCT = 59 h), and when the current tumour time is 60 h or greater the array starts to have the stacks recycled. See figure 3 for a flow chart of the cell division algorithm.
Modelled parameters.
Many biological parameters are included in the model. These are based on the literature average values wherever possible. These parameters include: the distribution of values for CCT, necrotic cell death rates, cell repair probabilities, stem cell symmetrical division probability etc. Quantitative values of some parameters are yet to be identified experimentally, and consequently have been applied in the model through estimated values or probability distributions. The applied parameters were then analysed for global effects over a wide but reasonable range of values. See table 1 for parameter values and references.
Algorithm efficiency.
Care was taken to design the cell division algorithm with a high computational efficiency. This meant designing the program code at a basic code level, with a minimum number of modules and pointers to in-built functions. The method of using a twodimensional array (where each column stores cells that are due to divide within the same hour of tumour time) to store cell data, was the most efficient way to store, access and manipulate data as the modelled cells divide, die and accumulate in the program. Other methods were explored (using other programming package, and using other linear vector approaches), but alternative methods either created more data to store or were slower in their processing times. data in clinical trials (Lartigau et al 1998 , Adam et al 1999 , as shown in figure 4 . This distribution is used in the Monte Carlo code which randomly assigns each cell a pO 2 value. As previously mentioned, as a cell divides one daughter cell receives the mother cell pO 2 level and the other daughter cell receives a value taken from the distribution shown in figure 4. To avoid a bias, the mother cell pO 2 level has an equal chance of being passed on to the first or second daughter cell.
Assigning of oxygen levels to the cell population.
The method of assigning oxygen levels to each cell from a set probability distribution is in contrast to other models which tend to use diffusion distances from uniformly spaced capillary cells (Borkenstein et al 2004 , Dasu et al 2005 , McElwain et al 1979 , or oxygen levels based on radial distances. The method has the benefits of being flexible, in that it can be easily interchanged for different oxygen data sets and because it can be changed during the growth period (or treatment) if required for a single simulation. It is also a simple and randomized method of assigning each cell an oxygen value, which is reasonable due to the spatial and temporal irregularity of hypoxia in advanced in vivo tumour systems (Ljungkvist et al 2002) .
Further, many models do not consider the range of oxygen levels which may lie between 0 and 100 mm Hg. The range is important due to the slowing of the cell cycle with decrease in the oxygen levels (Alarcon et al 2004 , Ljungkvist et al 2002 , Wilson et al 1995 , Gardner et al 2001 , Hirst and Denekamp 1979 ). In the model, a threshold for cell cycle arrest was applied for cells with very low oxygenation, as cells cannot survive in extreme hypoxic conditions and eventually die of necrosis, after arrest in the G1 phase of the cell cycle (Koritzinsky et al 2001) .
This threshold value was varied and the results analysed. Cells with oxygen levels above this threshold had their allocated cell cycle time increased by a factor between 1 and 3, according to the modelling work of Alarcon et al (2004) (figure 5). Cells with oxygen levels below the threshold become quiescent and are programmed to die, using a half life parameter. This parameter is modelled so that half of the hypoxic quiescent cells die at regular intervals. This means that hypoxic quiescent cells do not need their entire attribute data stored, rather a single counter parameter which counts the total number of cells can be utilized. This counter then reduces to half at the predetermined regular interval desired.
Results and discussion
Cell division and tumour growth properties
Percentages of different cell types in the cell population.
As mentioned in the previous section, normal epithelial tissue consists of a small percentage of stem cells, transit cells, differentiating cells and fully differentiated cells in the cell population. Assuming a relatively close relationship between these percentages in normal tissue compared to tumour tissue, the following cell type percentages resulted in the model, using the parameters displayed in table 1, and as seen in figures 6(a) and (b).
Influence of symmetrical stem cell division probability on tumour growth.
The results which follow show the influence of the symmetrical stem cell division probability on the tumour growth rate, tumour doubling times, total tumour growth times and the cell type percentages in the population. An increase in the symmetrical stem cell division probability (S%) parameter, has a major effect on the tumour growth curve, the total tumour growth time and the tumour doubling times. Altering the S% parameter to values between 1% and 5% resulted in a reduction in average tumour doubling times ranging from 116 to 23 days (figure 7).
Average tumour doubling times were calculated using total cell numbers which were recorded every 100 h, which were then averaged over the last 1000 h of tumour growth. Large fluctuations in the tumour doubling time are evident until approximately 1 year of tumour growth and may account for a 100 or more day difference in initial compared to the final tumour doubling times. The inverse relationship between tumour doubling time and total growth times with S% are shown in figures 8 and 9.
The choice for 'S%' of 3%, resulted in average tumour doubling times of approximately 40 ± 1 day in the model, which is consistent with the ranges reported in the literature of for head and neck squamous cell carcinomas (40-45 days, Steel (2002) and Denham (2001) ). A doubling time close to the lower doubling times reported in the literature was chosen because of the fully oxygenated state of the tumour during these simulations.
It is well known that when hypoxia begins to impact upon tumour growth, the doubling time will correspondingly increase, and as the majority of head and neck cancers have some hypoxic areas present at diagnosis, the true oxic tumour doubling time is likely to be even Figure 10 . An example of the processing time (array initialization and reading/writing to array elements) for the 2D object array versus 3D array data storage techniques, during model development.
smaller than presented here. In any case, a wide variation in growth rates among patients has been observed, and ideally a parameter set applicable to the individual patient should be used in the model (along with consideration of the current oxygenation status and tumour size).
Impact of the algorithm design
Variations in tumour growth due to random number seed.
The tumour growth program was run for many different random number seeds. Regardless of the choice of seed, the tumour doubling time settled to approximately 40-45 days, or 1.07 growth rate per 100 h (comparable to results reported by Marcu et al (2002) ) in all cases after 1.5 years of simulated tumour growth with all seeds having similar amplitude fluctuations. Relatively large fluctuations in the early stages of growth occur for most random seed choices, and were due to the small cell numbers and therefore increased variance in the number of stem cells in the early population.
Algorithm efficiency.
A two-dimensional (2D) array method for cell data storage was compared for computation efficiency to a three-dimensional (3D) array approach. The difference between to the two methods involves the use of 'objects' versus vectors to store cell attribute data. In the 2D case, a single array was used, where each cell or 'object' contained integer numbers. In the 3D case, an array of the same dimensions was declared, with the third dimension equal to 3 array elements. Here, each element is stored as a single integer value.
Early in the model development (3 attributes per cell modelled only) array initialization and read/write times were analysed, as shown in figure 10 . Overall, the 2D object array method was faster to process predominantly due to the large initialization time required for the 3D array method. The difference between reading and writing data from either a 2D object array or a 3D array was insignificant. The 3D approach had the disadvantage of requiring each element to have the same numerical precision, which was a waste of computer memory for those attributes requiring less than the standard single precision integers or real numbers (4-bytes). Currently, up to 10 7 cells may be propagated in ten to fifteen minutes on a standard PC using the 2D object approach to data storage, which has been a convenient for simulations. This has been achieved whilst maintaining individualized cell data. The time required to run the model increases approximately linearly with time. Currently, when cell numbers exceed 8 , the array required for data storage becomes too large for FORTRAN 95 to handle, unless manual overrides are performed. This limitation will be looked into in the future, so that cell propagation up to approximately 10 9 cells will become possible.
Modelling hypoxia
The distribution of oxygen in the modelled cell population.
With the use of the log normal shaped pO 2 distribution and the gradual slowing of the assigned cell cycle time according to pO 2 (linear relationship), the effect on cell quiescence of extreme hypoxia was investigated. It was found that only cells with pO 2 values less then 1-2 mm Hg could be arrested in the cell cycle, without causing tumour growth to slow too rapidly or stop completely, using the oxygen distribution in figure 4 . The percentages of cells in the very low pO 2 regions (< 1 to 2 mm Hg) is approximately 5%-10%, while the percentages <5 mm Hg and 10 mm Hg are 25% and 50%, respectively, as shown in figure 11(a) ). These figures are within the range of pO 2 values recorded in the literature from experimental studies predominantly using Eppendorf probes to measure in vivo oxygen tension within human HNSCC hypoxic tumours (Stadler et al 1998 , Lartigau et al 1998 , Nordsmark et al 1998 , Mason et al 1998 shown in figure 10(b) ). Literature values for these percentages often use 2.5, 5.0 or 10.0 mm Hg cut off points to define hypoxia; however, since pO 2 was assigned using integer values in the model, pO 2 values of 2, 5, 10 and 20 mm Hg were used as thresholds. 
The effects of hypoxia on tumour growth curves and doubling times.
A range of quiescence probabilities was assigned to cells with extreme hypoxia (<1 or 2 mm Hg), where growth curves are shown in figure 12 . The curve for 75% quiescence considering cells with pO 2 < 1 mm Hg is not considered plausible due to the reduction in cell numbers. It has been assumed that a tumour which has reached the point of hypoxia initiation does not reduce in cell number after this point in time. If this were the case, very few tumours would reach clinical sizes, in a hypoxic state. Based on a 50% probability of hypoxic cell quiescence for cells with a pO 2 value less than 1 mm Hg, tumour growth time increases from 2 to 3.5 years for a tumour of 10 7 cells. This probability hypoxic cell quiescence is estimated to be the most plausible, considering the effect on tumour growth after it is applied. Probability values which produce the effect of decreasing the number of tumour cells and were not considered plausible due to the prevalence of tumours that do grow to clinical sizes that exhibit hypoxia. These limits are approximately 70% if considering cell with pO 2 < 1 mm Hg, or 25% if considering all cell with pO 2 < 2 mm Hg.
If extended to a tumour consisting of 10 9 cells (using interpolation) and the same proliferative hierarchy and cell percentages, the total tumour growth time increases from 3 to 8 years. The precise value of pO 2 for which a hypoxic cell becomes quiescent is not clear from the literature. However, the level is likely to be low (0.2-1 mm Hg, Ljungkvist et al 2002) , which is further supported by the work previously mentioned and shown is in figure 4 (Alarcon et al 2004) . This likely low oxygen range for hypoxia induced cell quiescence, highlights the likelihood of tumour cells be subjected to relatively low oxygen pressures of 10 mm Hg or less (and consequential increase in radioresistance of 20% to 60%), whilst maintaining division capability.
With a great proportion of cells having a high probability of being quiescent, and another great proportion of cells having an oxygen level low enough to slow the cells cycle, it is reasonable to conclude that the increase in tumour doubling time in hypoxic tumours should be more than two-fold in poorly oxygenated tumours (since ∼50% of cells have a pO 2 < 2.5 mm Hg in poorly oxygenated tumours, Dasu et al (2005) ). Likely hypoxic quiescence limits and probabilities are displayed in figure 13 , where a 50% quiescence probability for cells with a pO 2 < 1 mm Hg increases TD from 40 to 220 days. This is within the range of tumour doubling times (20-240 days) of a HNSCC patient whilst waiting for radiotherapy treatment, which includes tumours with a variety of oxygenation levels (Jensen et al 2007) . Varying the quiescent hypoxic cell half life from 4 to 10 days did not make a significant change to the tumour growth rate. This is because these cells are no longer cycling and do not play a role in increasing tumour volume. The only difference between the cell population statistics for simulation which vary this parameter is the overall increasing in quiescent hypoxic cell number by 3%. However, the increase in growth time was non-significant compared to variations seen through the variation in random number seed (<20 days).
Until more quantitative data are available, future simulations will be based on a 4 day hypoxic cell half life and 50% extreme (pO 2 < 1 mm Hg) hypoxic cell quiescence. This, along with the log-normal pO 2 distribution used results in an approximate 20% hypoxic fraction (cells having pO 2 < 10 mm Hg), with 9% of cells having a pO 2 less than 2 mm Hg, and 4% of the cell population in hypoxia induced cell cycle arrest. This tumour would fall between the categories of poorly to moderately hypoxic (Dasu et al 2005) and is in line with the median percentage of cells (15%) below 2.5 mm Hg in from a study by Nordsmark et al (1996) , involving 35 head and neck cancer patients.
Conclusions
A tumour growth model algorithm has been designed and implemented in the FORTRAN 95 programming language. It models the individual cell division of epithelial cells with a plausible cell hierarchy structure and literature researched tumour cell parameters. The algorithm is efficient in time and for memory capacity, which is achieved through an object oriented 2D cell array approach to data storage. A plausible and experimentally verified oxygen distribution has been used to randomly assign each cell a pO 2 (mm Hg) value upon entry into the cell cycle, where one daughter cells receives the mother cell pO 2 and the second daughter cell receives a random pO 2 from the distribution. The distribution is log-normal in shape which agrees well with in vivo data from the literature (Lartigau et al 1998 , Adam et al 1999 .
The stem cell population percentage dominates the rate of tumour growth for fully oxygenated simulated tumours. There is a linear relationship between the stem cell population percentage and the average tumour growth rate and an exponential relationship between stem cell population percentage and the tumour doubling time. The implementation of a realistic oxygen distribution among the tumour cells had the effect of increasing the tumour growth time and tumour doubling time. This is due to the slowing of the cell cycle for moderately hypoxic cells and cell cycle arrest of cells under extreme hypoxia. The oxygenation attribute was applied to all cell types equally and consequently slowed the growth due to a decreased proliferation rate of stem and transit cells.
The pO 2 limit for cell quiescence had a large impact on the decrease in tumour growth rate. A plausible pO 2 value for hypoxia induced quiescence has been found to lie above 0 mm and below 2 mm Hg. Using a 50% probability for cells with a pO 2 < 1 mm Hg to become quiescent, the growth time was increased by 1.5 years for a 10 7 cell tumour and 5 years for a 10 9 cell tumour. The corresponding tumour doubling time increased from around 40 days to over 200 days for an oxygenated versus hypoxic tumour using this probability, which is a plausible result for a hypoxic tumour (Jensen et al 2007) .
This study has outlined the need for specific cellular based parameters, if individualized tumour modelling is to become routine practice for radiotherapy planning. With such a large range of plausible values and distributions, such as the distribution of oxygen, it is crucial that more experimental studies be performed based on the development of relatively quick and non-invasive procedures on cancer patients prior to treatment (as well as during treatment in the cases of accelerated repopulation and reoxygenation). The lower limit for oxygen deprivation induced cell cycle arrest needs further investigation to determine if the limit differs between different cell types and tumours, as well as experimental and quantitative evidence of the degree of cell cycle time increase for moderate levels of hypoxia.
It is the intention of the authors to perform in vivo xenograft studies to measure and verify the pO 2 distribution within the HNSCC tumour system before and during fractionated radiotherapy. The model will also be extended to include response to radiotherapy, which can be directly compared to clinical trial data on local control outcomes from specific stratified patient groups (Nordsmark et al 2005 , Dunst et al 2003 , Stadler et al 1999 . Reoxygenation dynamics and accelerated repopulation phenomenon will be key features of future versions of this tumour growth and radiotherapy model.
